Quantinno Capital Management LP Acquires 4,939 Shares of iShares Biotechnology ETF $IBB

Quantinno Capital Management LP grew its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 33.0% in the 1st quarter, Holdings Channel reports. The fund owned 19,892 shares of the financial services provider’s stock after buying an additional 4,939 shares during the period. Quantinno Capital Management LP’s holdings in iShares Biotechnology ETF were worth $3,359,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently made changes to their positions in IBB. Lazard Asset Management LLC boosted its stake in shares of iShares Biotechnology ETF by 28.0% in the 1st quarter. Lazard Asset Management LLC now owns 1,138 shares of the financial services provider’s stock valued at $192,000 after purchasing an additional 249 shares in the last quarter. Matrix Private Capital Group LLC bought a new position in iShares Biotechnology ETF in the 1st quarter valued at approximately $68,000. Compound Planning Inc. boosted its position in iShares Biotechnology ETF by 3.9% in the first quarter. Compound Planning Inc. now owns 2,011 shares of the financial services provider’s stock valued at $340,000 after buying an additional 75 shares in the last quarter. Cetera Investment Advisers boosted its position in iShares Biotechnology ETF by 9.4% in the first quarter. Cetera Investment Advisers now owns 128,530 shares of the financial services provider’s stock valued at $21,702,000 after buying an additional 10,994 shares in the last quarter. Finally, Aureus Asset Management LLC bought a new stake in shares of iShares Biotechnology ETF during the first quarter worth $203,000. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Up 2.5%

NASDAQ IBB opened at $197.71 on Friday. The firm’s fifty day moving average price is $183.84 and its two-hundred day moving average price is $175.35. iShares Biotechnology ETF has a fifty-two week low of $131.36 and a fifty-two week high of $199.05.

iShares Biotechnology ETF Cuts Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, June 18th. Shareholders of record on Monday, June 15th were issued a $0.0238 dividend. This represents a $0.10 dividend on an annualized basis and a yield of 0.0%. The ex-dividend date of this dividend was Monday, June 15th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.